← Leaderboards
Catherine Gutierrez
Harvard Medical School
$122,471
Attributed
$122,471
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.9K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$122,471 · 1
By mechanism
F31$122,471 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Jean Fan$2,354,045
- Allon Moshe Klein$7,807,178
- Michael J Volles$165,894
- Rahul N Kanadia$3,325,872
- Courtney Michelle Whilden$116,323
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAnabolismAtr GeneAutomobile DrivingBiologyB-LymphocytesCd19 GeneCell Growth RegulationCell LineCell PhysiologyCellsChromosome 13q LossChromosome 17p LossChronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia CellCohortComplexCrispr/Cas TechnologyDiamond-Blackfan AnemiaDna Sequence AlterationDrug ResistanceEffective TherapyEventAdult
Grant awards (3)
Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia$48,883
F31 · FY2021 · CA · contact PI
Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia$37,046
F31 · FY2020 · CA · contact PI
Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia$36,542
F31 · FY2019 · CA · contact PI